Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic Ointment (Sterile) -VETERINARY

Neomycin and polymyxin B sulfates and bacitracin zinc by

Drug Labeling and Warnings

Neomycin and polymyxin B sulfates and bacitracin zinc by is a Animal medication manufactured, distributed, or labeled by BUTLER ANIMAL HEALTH SUPPLY, LLC DBA COVETRUS NORTH AMERICA, Akorn Operating Company LLC, Akorn, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC- neomycin sulfate and polymyxin b sulfate and bacitracin zinc ointment 
BUTLER ANIMAL HEALTH SUPPLY, LLC DBA COVETRUS NORTH AMERICA

----------

Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic Ointment (Sterile) -VETERINARY

ANADA 200-553, Approved by FDA

DESCRIPTION:

Each gram contains: polymyxin B sulfate 10,000 units, bacitracin zinc 400 units, neomycin sulfate 5 mg (equivalent to 3.5 mg neomycin base) in a white petrolatum base, q.s.

ACTIONS:

Polymyxin B is one of a group of closely related substances produced by various strains of Bacillus polymyxa. The activity of polymyxin B is sharply restricted to gram-negative bacteria. Neomycin, isolated from Streptomyces fradiae, has antibacterial activity in vitro against a wide range of gram-negative and gram-positive organisms. Bacitracin, an antibiotic substance derived from cultures of Bacillus subtilis (Tracy), exerts antibacterial action in vitro against a variety of gram-positive and a few gram-negative organisms.

INDICATIONS:

This product is indicated for the treatment of superficial bacterial infections of the eyelid and conjunctiva of dogs and cats when due to organisms susceptible to one or more of the antibiotics contained in the ointment.

Laboratory tests should be conducted including in vitro culturing and susceptibility tests on samples collected prior to treatment.

PRECAUTIONS:

If irritation develops discontinue treatment with this drug. If there is no response to treatment in 2 to 3 days, discontinue treatment and re-evaluate diagnosis. Prolonged use may result in overgrowth of nonsusceptible organisms, including fungi.

Care should be taken not to contaminate the applicator tip during administration of the preparation.

ADVERSE REACTIONS:

Adverse reactions, such as itching, burning, or inflammation may occur in animals sensitive to this product.

DOSAGE AND ADMINISTRATION:

Properly cleanse area to be treated. Foreign bodies, crusted exudates and debris should be carefully removed. Express a small quantity of ointment into the conjunctival sac beneath the lower eyelid three or four times daily. After application hold the eyelids shut for a short time so that a thin film of ointment covers the cornea.

HOW SUPPLIED:

NDC: 11695-6841-3

Tube of 3.5 g (1/8 oz) with ophthalmic tip.

STORAGE:

Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temp].

KEEP OUT OF REACH OF CHILDREN.

Not for Human Use.

CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.

Warning: Serious hypersensitivity (anaphylactic) reactions have been reported in cats within 4 hours of application of antibiotic ophthalmic preparations. Some of these reactions have resulted in death.

covetrus®

Questions?

(855) 724-3461

Distributed by:
Covetrus North America
400 Metro Place North
Dublin, OH 43017

covetrus.com

HNPB00N   REV. 0121       AH-071986-01

Principal Display Panel Text for Container Label:

Covetrus logo Reorder #071986

NDC: 11695-6841-3

Neomycin and polymyxin B sulfates, and

bacitracin zinc ophthalmic ointment, USP

For veterinary use only ANADA 200-553, Approved by FDA

Sterile ophthalmic ointment Rx only Net Wt. 3.5 g (1/8 oz.)

Principal Display Panel Text for Carton Label:

Covetrus logo Reorder #071986

NDC: 11695-6841-3

Neomycin and polymyxin B sulfates, and

bacitracin zinc ophthalmic ointment, USP

Sterile Ophthalmic Ointment For veterinary use only Rx only

Net Wt. 3.5 g (1/8 oz.) ANADA 200-553, Approved by FDA

NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC 
neomycin sulfate and polymyxin b sulfate and bacitracin zinc ointment

Product Information
Product Type	PRESCRIPTION ANIMAL DRUG	Item Code (Source)	NDC: 11695-6841
Route of Administration	OPHTHALMIC

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
polymyxin B sulfate (UNII: 19371312D4) (polymyxin B - UNII:J2VZ07J96K)	polymyxin B	10000 [USP'U]  in 1 g
neomycin sulfate (UNII: 057Y626693) (neomycin - UNII:I16QD7X297)	neomycin	3.5 mg  in 1 g
bacitracin zinc (UNII: 89Y4M234ES) (bacitracin - UNII:58H6RWO52I)	bacitracin zinc	400 [USP'U]  in 1 g

Inactive Ingredients
Ingredient Name	Strength
Petrolatum (UNII: 4T6H12BN9U)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 11695-6841-3	1 in 1 CARTON
1		3.5 g in 1 TUBE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
ANADA	ANADA200553	10/27/2021	05/31/2023

Labeler - BUTLER ANIMAL HEALTH SUPPLY, LLC DBA COVETRUS NORTH AMERICA (603750329)

Registrant - Akorn Operating Company LLC (117693100)

Establishment
Name	Address	ID/FEI	Business Operations
Akorn		117696840	MANUFACTURE, ANALYSIS, STERILIZE, PACK, LABEL

Revised: 11/2023

Document Id: ea8c6e21-764a-47e3-8310-b1ec22051e1d

50578-4

Set id: fc910fa7-be48-46bc-8bb8-55030dc67a45

Version: 3

Effective Time: 20231127

 

BUTLER ANIMAL HEALT